pyrrolidin-2-yl-thiazol-2-yl-methanol | 689217-70-7

• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: pyrrolidin-2-yl-thiazol-2-yl-methanol
• 英文别名: [(2S)-pyrrolidin-2-yl]-(1,3-thiazol-2-yl)methanol
• CAS: 689217-70-7
• 化学式: C₈H₁₂N₂OS
• 分子量: 184.262
• InChiKey: CBHWEWNDFNASKF-PKPIPKONSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.3
• 重原子数：
  12
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.62
• 拓扑面积：
  73.4
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  pyrrolidin-2-yl-thiazol-2-yl-methanol 在 草酰氯 、 1-羟基苯并三唑 、 二甲基亚砜 、 1-(3-二甲基氨基丙基)-3-乙基碳二亚胺 、 三乙胺 作用下， 反应 0.5h， 生成 2-<<1-<<1-(4-phenylbutanoyl)-2(S)-pyrrolidinyl>carbonyl>-2(R)-pyrrolidinyl>carbonyl>thiazole
  参考文献：
  名称：

  Synthesis and Structure-Activity Relationships of Peptidyl .alpha.-Keto Heterocycles as Novel Inhibitors of Prolyl Endopeptidase

  摘要：

  The preparation and in vitro prolyl endopeptidase (PEP) inhibitory activity of a series of alpha-keto heterocyclic compounds is described. The design is based on the introduction of alpha-keto heterocycles at the C-terminal end of substrate-like peptides. Many of the compounds including those substituted with thiazole, benzothiazole, benzoxazole, imidazole, and pyridine groups exhibit IC50 potencies of PEP inhibition at nanomolar levels. Structure-activity studies of the C-terminal heterocyclic groups indicate the importance of an sp(2) nitrogen atom at a beta-position from the adjoining ketone carbonyl group. This heterocyclic nitrogen atom would provide a critical hydrogen-bond interaction with the histidine residue of the catalytic triad in PEP. Our inhibitors would extend the generality of the alpha-keto heterocycle design to another serine protease.

  DOI：

  10.1021/jm00047a007
• 作为产物：
  描述：

  (S)-N-Boc-吡咯烷-2-甲醛 N-(叔丁氧羰基)-L-脯氨醛 在 正丁基锂 、 三氟乙酸 作用下， 以 二氯甲烷 为溶剂， 反应 5.0h， 生成 pyrrolidin-2-yl-thiazol-2-yl-methanol
  参考文献：
  名称：

  Synthesis and Structure-Activity Relationships of Peptidyl .alpha.-Keto Heterocycles as Novel Inhibitors of Prolyl Endopeptidase

  摘要：

  The preparation and in vitro prolyl endopeptidase (PEP) inhibitory activity of a series of alpha-keto heterocyclic compounds is described. The design is based on the introduction of alpha-keto heterocycles at the C-terminal end of substrate-like peptides. Many of the compounds including those substituted with thiazole, benzothiazole, benzoxazole, imidazole, and pyridine groups exhibit IC50 potencies of PEP inhibition at nanomolar levels. Structure-activity studies of the C-terminal heterocyclic groups indicate the importance of an sp(2) nitrogen atom at a beta-position from the adjoining ketone carbonyl group. This heterocyclic nitrogen atom would provide a critical hydrogen-bond interaction with the histidine residue of the catalytic triad in PEP. Our inhibitors would extend the generality of the alpha-keto heterocycle design to another serine protease.

  DOI：

  10.1021/jm00047a007

文献信息

• [EN] NOVEL INHIBITORS OF DIPEPTIDYL PEPTIDASE IV<br/>[FR] NOUVEAUX INHIBITEURS DE DIPEPTIDYL PEPTIDASE IV
  申请人：GUILFORD PHARM INC

  公开号：WO2004041795A1

  公开（公告）日：2004-05-21

  Novel inhibitors of dipeptidyl peptidase IV (DPP IV), pharmaceutical compositions comprising therapeutically effective amounts of novel inhibitors of DPP IV, and novel methods of treating medical conditions are provided. The novel inhibitors of DPP IV described herein are useful in the treatment of neurological disorders, diabetes, inflammatory disorders such as arthritis, obesity, osteoporosis, and of such other enumerated conditions as can be treated with inhibitors of DPP IV.

  本发明提供了新型二肽基肽酶IV（DPP IV）抑制剂、包含治疗有效量新型DPP IV抑制剂的制药组合物，以及治疗医学疾病的新方法。本发明所描述的新型DPP IV抑制剂在治疗神经系统疾病、糖尿病、炎症性疾病（如关节炎）、肥胖症、骨质疏松症以及其他可用DPP IV抑制剂治疗的疾病方面具有用途。
• Synthesis and Structure-Activity Relationships of Peptidyl .alpha.-Keto Heterocycles as Novel Inhibitors of Prolyl Endopeptidase
  作者：Seiji Tsutsumi、Tsuneo Okonogi、Seiji Shibahara、Shokichi Ohuchi、Emiko Hatsushiba、Arthur A. Patchett、Burton G. Christensen

  DOI：10.1021/jm00047a007

  日期：1994.10

  The preparation and in vitro prolyl endopeptidase (PEP) inhibitory activity of a series of alpha-keto heterocyclic compounds is described. The design is based on the introduction of alpha-keto heterocycles at the C-terminal end of substrate-like peptides. Many of the compounds including those substituted with thiazole, benzothiazole, benzoxazole, imidazole, and pyridine groups exhibit IC50 potencies of PEP inhibition at nanomolar levels. Structure-activity studies of the C-terminal heterocyclic groups indicate the importance of an sp(2) nitrogen atom at a beta-position from the adjoining ketone carbonyl group. This heterocyclic nitrogen atom would provide a critical hydrogen-bond interaction with the histidine residue of the catalytic triad in PEP. Our inhibitors would extend the generality of the alpha-keto heterocycle design to another serine protease.